Pfizer chief Albert Bourla wins $1 million Genesis Prize
The Hindu
Albert Bourla, chairman and chief executive of global pharmaceutical giant Pfizer Inc., was awarded on January 19 the prestigious Genesis Prize for his efforts in leading the development of a COVID-19
Albert Bourla, chairman and chief executive of global pharmaceutical giant Pfizer Inc., was awarded on January 19 the prestigious Genesis Prize for his efforts in leading the development of a COVID-19 vaccine.
The $1 million award is granted each year to a person for their professional achievements, contributions to humanity and commitment to Jewish values. The Genesis Prize Foundation said Mr. Bourla had received the largest number of votes in an online campaign in which some 2,00,000 people in 71 countries participated.
It commended him for his “leadership, determination, and especially for his willingness to assume great risks.” It cited Pfizer's decision to turn down U.S. government funding early in the pandemic, a decision that helped the company reduce bureaucracy and expedite development of the vaccine.